Clene Research Development from 2010 to 2026

CLNN Stock  USD 4.17  0.08  1.96%   
Clene Research Development yearly trend continues to be very stable with very little volatility. Research Development is likely to drop to about 21.6 M. During the period from 2010 to 2026, Clene Research Development quarterly data regression pattern had sample variance of 86.4 T and median of  6,645,000. View All Fundamentals
 
Research Development  
First Reported
2019-03-31
Previous Quarter
3.5 M
Current Value
3.5 M
Quarterly Volatility
2.2 M
 
Covid
 
Interest Hikes
Check Clene financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Clene's main balance sheet or income statement drivers, such as Other Operating Expenses of 29.1 M, Total Operating Expenses of 28.9 M or Depreciation And Amortization of 1.2 M, as well as many indicators such as Price To Sales Ratio of 118, Dividend Yield of 0.0 or Days Sales Outstanding of 456. Clene financial statements analysis is a perfect complement when working with Clene Valuation or Volatility modules.
  
Build AI portfolio with Clene Stock
Check out the analysis of Clene Correlation against competitors.
Evaluating Clene's Research Development across multiple reporting periods reveals the company's ability to sustain growth and manage resources effectively. This longitudinal analysis highlights inflection points, cyclical patterns, and structural changes that short-term snapshots might miss, offering deeper insight into Clene Inc's fundamental strength.

Latest Clene's Research Development Growth Pattern

Below is the plot of the Research Development of Clene Inc over the last few years. It is Clene's Research Development historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Clene's overall financial position and show how it may be relating to other accounts over time.
Research Development10 Years Trend
Slightly volatile
   Research Development   
       Timeline  

Clene Research Development Regression Statistics

Arithmetic Mean13,854,126
Geometric Mean11,313,040
Coefficient Of Variation67.07
Mean Deviation8,232,148
Median6,645,000
Standard Deviation9,292,582
Sample Variance86.4T
Range25.3M
R-Value0.80
Mean Square Error33.1T
R-Squared0.64
Significance0.0001
Slope1,473,109
Total Sum of Squares1381.6T

Clene Research Development History

202621.6 M
202523.1 M
202420.1 M
202326.7 M
202231.9 M
202128.4 M
202015.2 M

About Clene Financial Statements

Clene investors utilize fundamental indicators, such as Research Development, to predict how Clene Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
Last ReportedProjected for Next Year
Research Development23.1 M21.6 M

Pair Trading with Clene

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Clene position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Clene will appreciate offsetting losses from the drop in the long position's value.

Moving against Clene Stock

  0.86VNDA Vanda PharmaceuticalsPairCorr
  0.8VRTX Vertex Pharmaceuticals Earnings Call This WeekPairCorr
  0.76WHWK Whitehawk Therapeutics Symbol ChangePairCorr
  0.75FHTX Foghorn TherapeuticsPairCorr
  0.75GMAB Genmab ASPairCorr
The ability to find closely correlated positions to Clene could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Clene when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Clene - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Clene Inc to buy it.
The correlation of Clene is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Clene moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Clene Inc moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Clene can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
When determining whether Clene Inc offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Clene's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Clene Inc Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Clene Inc Stock:
Check out the analysis of Clene Correlation against competitors.
You can also try the Portfolio Anywhere module to track or share privately all of your investments from the convenience of any device.
Will Biotechnology sector continue expanding? Could Clene diversify its offerings? Factors like these will boost the valuation of Clene. Projected growth potential of Clene fundamentally drives upward valuation adjustments. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Clene data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Quarterly Earnings Growth
0.614
Earnings Share
(3.36)
Revenue Per Share
0.023
Quarterly Revenue Growth
(0.83)
Return On Assets
(0.56)
Understanding Clene Inc requires distinguishing between market price and book value, where the latter reflects Clene's accounting equity. The concept of intrinsic value—what Clene's is actually worth based on fundamentals—guides informed investors toward better entry and exit points. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Market sentiment, economic cycles, and investor behavior can push Clene's price substantially above or below its fundamental value.
It's important to distinguish between Clene's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Clene should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. In contrast, Clene's trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.